Fibrosis Nerandomilast Shows Promising Phase III Results for Progressive Pulmonary Fibrosis 13/02/2025 Inflammation/Fibrosis Fibrosis-inflammation Lab
Lung Clinical Practice Guideline Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) 13/12/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Kidney Understanding Renal Fibrosis: Insights from the Unilateral Ureter Obstruction (UUO) Model 12/12/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Lung COPD and Pulmonary Fibrosis: Understanding the Interconnection and Advances in Clinical Trials 11/12/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Kidney The Importance and Application of Mouse Models in Kidney Fibrosis Research 10/12/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Liver FDA Announces Priority Review of Resmetirom: A Promising Treatment for NASH Patients 18/09/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Model mouse Unraveling the UUO Mouse Model: Insights into Renal Fibrosis and Therapeutic Opportunities 06/05/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Publication Publication: Targeting TGF-β signal transduction for fibrosis and cancer therapyPublication 05/05/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Publication Publication: Targeting TGF-β signal transduction for fibrosis and cancer therapyPublication 05/05/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
Fibrosis Nerandomilast Shows Promising Phase III Results for Progressive Pulmonary Fibrosis 13/02/2025 Inflammation/Fibrosis Fibrosis-inflammation Lab
Fibrosis 線維化のメカニズムと治療法: 病態モデルマウスと非臨床CROの役割 08/04/2023 Inflammation/Fibrosis Fibrosis-inflammation Lab
